DelveInsight's "DARZALEX Market Size, Forecast, and Market Insight Report" highlights the details around DARZALEX, a human ...

A pair of privately-held developers of editing-based therapies have some successes to show for their recent efforts to ...

Visen Pharmaceuticals, a biotech developing much of Ascendis Pharma’s endocrine-related disease pipeline for the China market ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Precigen (PGEN – Research Report) and Edwards Lifesciences ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Avalo Therapeutics (AVTX – Research Report) and ...

Cathie Wood's Ark Invest sold $4.3 million worth of Meta shares on Wednesday, March 19, 2025, despite the company's Llama AI reaching 1 billion downloads.

Biotech is an area that may offer your portfolio growth today and earnings stability tomorrow. The idea is a biotech stock ...

Reuters reported that President Trump’s tariffs have impacted the broader stock markets, weighing on investors’ sentiments, ...

Shares of CRISPR Therapeutics CRSP closed at $40.97 on Tuesday, close to their 52-week low of $36.52. This decline in CRSP ...

We came across a bullish thesis on CRISPR Therapeutics AG (CRSP) on wallstreetbets Subreddit Page by MADD-Scientis. In this ...

The future of medicine is being shaped by a confluence of factors at play. If there are worries galore around drug resistant ...

The firm will use the funds to develop its lead candidate in primary hyperoxaluria type 1 and other pipeline products in liver and CNS disorders.